Noninvasive Neurally Adjusted Ventilation in Postextubation Stabilization of Preterm Infants: A Randomized Controlled...

Area of Science:

• Neonatology
• Pediatric Respiratory Medicine
• Critical Care

Background:

• Preterm infants often require mechanical ventilation and face challenges with extubation.
• Extubation failure in preterm infants can lead to increased morbidity and mortality.
• Optimizing noninvasive respiratory support post-extubation is crucial for improved outcomes.

Purpose of the Study:

• To compare the efficacy of noninvasive neurally adjusted ventilatory assist (NIV-NAVA) versus nasal continuous positive airway pressure (NCPAP) in preterm infants.
• To determine which ventilatory support method reduces extubation failure rates within 72 hours.
• To assess the impact of NIV-NAVA and NCPAP on diaphragmatic electrical activity post-extubation.

Main Methods:

• A prospective, single-center randomized controlled trial was conducted.
• Preterm infants (<30 weeks gestation) requiring invasive ventilation were randomized to NIV-NAVA or NCPAP post-extubation.
• Primary outcome was extubation failure within 72 hours; secondary outcomes included diaphragmatic electrical activity (Edi).

Main Results:

• Extubation failure within 72 hours was significantly lower in the NIV-NAVA group (8.6%) compared to the NCPAP group (28.6%) (P=0.031).
• Peak and swing Edi values were similar initially but lower in the NIV-NAVA group at later time points (4, 12, 24 hours).
• No significant differences were observed in the duration of respiratory support or severe bronchopulmonary dysplasia incidence between groups.

Conclusions:

• NIV-NAVA demonstrated superior effectiveness in preventing extubation failure in preterm infants compared to NCPAP.
• NIV-NAVA may facilitate more efficient respiratory recovery post-extubation.
• These findings support the use of NIV-NAVA as a preferred strategy for extubation in preterm neonates.